134 related articles for article (PubMed ID: 10869747)
1. Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors.
Haustermans K; Hofland I; Van de Pavert L; Geboes K; Varia M; Raleigh J; Begg AC
Radiother Oncol; 2000 Jun; 55(3):325-33. PubMed ID: 10869747
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR.
Begg AC; Janssen H; Sprong D; Hofland I; Blommestijn G; Raleigh JA; Varia M; Balm A; Van Velthuyzen L; Delaere P; Sciot R; Haustermans KMG
Acta Oncol; 2001; 40(8):924-8. PubMed ID: 11845956
[TBL] [Abstract][Full Text] [Related]
3. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.
Kennedy AS; Raleigh JA; Perez GM; Calkins DP; Thrall DE; Novotny DB; Varia MA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):897-905. PubMed ID: 9128967
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
Goethals L; Debucquoy A; Perneel C; Geboes K; Ectors N; De Schutter H; Penninckx F; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):246-54. PubMed ID: 16618579
[TBL] [Abstract][Full Text] [Related]
5. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
Janssen HL; Haustermans KM; Sprong D; Blommestijn G; Hofland I; Hoebers FJ; Blijweert E; Raleigh JA; Semenza GL; Varia MA; Balm AJ; van Velthuysen ML; Delaere P; Sciot R; Begg AC
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1537-49. PubMed ID: 12459383
[TBL] [Abstract][Full Text] [Related]
6. Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.
Nordsmark M; Loncaster J; Aquino-Parsons C; Chou SC; Ladekarl M; Havsteen H; Lindegaard JC; Davidson SE; Varia M; West C; Hunter R; Overgaard J; Raleigh JA
Radiother Oncol; 2003 Apr; 67(1):35-44. PubMed ID: 12758238
[TBL] [Abstract][Full Text] [Related]
7. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
8. Semiquantitative immunohistochemical analysis for hypoxia in human tumors.
Raleigh JA; Chou SC; Bono EL; Thrall DE; Varia MA
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):569-74. PubMed ID: 11173156
[TBL] [Abstract][Full Text] [Related]
9. Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumors.
Janssen HL; Hoebers FJ; Sprong D; Goethals L; Williams KJ; Stratford IJ; Haustermans KM; Balm AJ; Begg AC
Radiother Oncol; 2004 Jan; 70(1):91-7. PubMed ID: 15036858
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin.
Azuma Y; Chou SC; Lininger RA; Murphy BJ; Varia MA; Raleigh JA
Clin Cancer Res; 2003 Oct; 9(13):4944-52. PubMed ID: 14581369
[TBL] [Abstract][Full Text] [Related]
11. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
Airley RE; Loncaster J; Raleigh JA; Harris AL; Davidson SE; Hunter RD; West CM; Stratford IJ
Int J Cancer; 2003 Mar; 104(1):85-91. PubMed ID: 12532423
[TBL] [Abstract][Full Text] [Related]
12. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
Nordsmark M; Loncaster J; Chou SC; Havsteen H; Lindegaard JC; Davidson SE; Varia M; West C; Hunter R; Overgaard J; Raleigh JA
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):581-6. PubMed ID: 11173158
[TBL] [Abstract][Full Text] [Related]
13. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
Olive PL; Durand RE; Raleigh JA; Luo C; Aquino-Parsons C
Br J Cancer; 2000 Dec; 83(11):1525-31. PubMed ID: 11076663
[TBL] [Abstract][Full Text] [Related]
14. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
Hoogsteen IJ; Lok J; Marres HA; Takes RP; Rijken PF; van der Kogel AJ; Kaanders JH
Eur J Cancer; 2009 Nov; 45(16):2906-14. PubMed ID: 19699082
[TBL] [Abstract][Full Text] [Related]
16. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
[TBL] [Abstract][Full Text] [Related]
17. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas.
Wijffels KI; Kaanders JH; Rijken PF; Bussink J; van den Hoogen FJ; Marres HA; de Wilde PC; Raleigh JA; van der Kogel AJ
Br J Cancer; 2000 Sep; 83(5):674-83. PubMed ID: 10944611
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.
Raleigh JA; Calkins-Adams DP; Rinker LH; Ballenger CA; Weissler MC; Fowler WC; Novotny DB; Varia MA
Cancer Res; 1998 Sep; 58(17):3765-8. PubMed ID: 9731480
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
van Laarhoven HW; Kaanders JH; Lok J; Peeters WJ; Rijken PF; Wiering B; Ruers TJ; Punt CJ; Heerschap A; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):473-82. PubMed ID: 16242253
[TBL] [Abstract][Full Text] [Related]
20. Quantifying transient hypoxia in human tumor xenografts by flow cytometry.
Bennewith KL; Durand RE
Cancer Res; 2004 Sep; 64(17):6183-9. PubMed ID: 15342403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
